SCHEMBL24590090

SCHEMBL24590090

CCN(CC)c1ccc2c(C)c(CCOC(=O)NCc3cccc(CCC(=O)OC)c3)c(=O)oc2c1

nearest known ligand 0.79

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ IGLV6-57 P01721 10/20 0.79
▸ KDM4E B2RXH2 4/20 0.54
▸ ALDH1A1 P00352 4/20 0.54
▸ GLA P06280 3/20 0.54
▸ MAPT P10636 3/20 0.54
▸ ATM Q13315 2/20 0.54
▸ CASP1 P29466 2/20 0.54
▸ CASP7 P55210 2/20 0.54
▸ HSD17B10 Q99714 2/20 0.54
▸ HTT P42858 2/20 0.54
▸ THRB P10828 2/20 0.54
▸ LMNA P02545 1/20 0.54
▸ L3MBTL1 Q9Y468 1/20 0.54
▸ GAA P10253 3/20 0.49
▸ KLK7 P49862 1/20 0.49
▸ SRC P12931 2/20 0.47
▸ HPGD P15428 1/20 0.44
▸ TDP1 Q9NUW8 1/20 0.44
▸ TP53 P04637 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22501654 0.93 IGLV6-57 (0.83) IGLV6-57KDM4EALDH1A1GLAMAPT
SCHEMBL29694188 0.90 IGLV6-57 (0.81) IGLV6-57KDM4EALDH1A1GLAMAPT
SCHEMBL24590115 0.90 IGLV6-57 (0.81) IGLV6-57KDM4EALDH1A1GLAMAPT
SCHEMBL24590000 0.88 IGLV6-57 (1.00) IGLV6-57KDM4EALDH1A1GLAMAPT
SCHEMBL22501686 0.88 IGLV6-57 (0.60) IGLV6-57KDM4EALDH1A1GLAMAPT
SCHEMBL22501772 0.87 IGLV6-57 (0.86) IGLV6-57KDM4EALDH1A1GLAMAPT
SCHEMBL24589821 0.86 IGLV6-57 (1.00) IGLV6-57KDM4EALDH1A1GLAMAPT
SCHEMBL24590100 0.86 IGLV6-57 (0.80) IGLV6-57KDM4EALDH1A1GLAMAPT
SCHEMBL24590078 0.86 IGLV6-57 (1.00) IGLV6-57KDM4EALDH1A1GLAMAPT
SCHEMBL24589820 0.86 IGLV6-57 (0.84) IGLV6-57KDM4EALDH1A1GLAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220204485-A1 STABILIZATION OF AMYLOIDOGENIC IMMUNOGLOBULIN LIGHT CHAINS THE SCRIPPS RESEARCH INSTITUTE 2022-06-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220204485-A1 STABILIZATION OF AMYLOIDOGENIC IMMUNOGLOBULIN LIGHT CHAINS TTR, MAP1LC3B, SAAL1 IGLV6-57 7/4885KDM4E 4575/4885ALDH1A1 2072/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback